IP Library Granted Patent US 12,324,641
Granted Patent B2
US 12,324,641 · App. 18/593,464 · Granted Jun 10, 2025

Artificial intelligence for robotic surgery

Inventors: Nikolai Aljuri (Hillsborough, CA); Surag Mantri (East Palo Alto, CA); Kevin Staid (Lowell, MA)
Assignee: PROCEPT BioRobotics Corporation
A61B34/30A61B34/10A61B2034/104A61B2034/107A61B2034/108
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,324,641
App. No.
18/593,464
Granted
Jun 10, 2025
Kind
B2
Abstract

An apparatus for robotic surgery comprises a processor configured with instructions to receive patient data from treated patients, receive surgical robotics data for each of the plurality of treated patients, and output a treatment plan of a patient to be treated in response to the patient data and the surgical robotics data. This approach has the advantage of accommodating individual variability among patients and surgical system parameters so as to provide improved treatment outcomes.

Claims (31)

1. An apparatus to treat tissue of a prostate of a patient, the apparatus comprising:

a display;

a processor operatively coupled to the display; and

memory comprising instructions that when executed by the processor, cause the apparatus to,

receive an image of the prostate,

identify delicate a tissue structure of the prostate based on the image, and

generate, using a trained classifier, a treatment plan for treating a lobe of the prostate, the treatment plan including a tissue removal profile for the lobe of the prostate,

display the tissue removal profile on the display,

receive a user input to adjust the tissue removal profile shown on the display to generate an adjusted tissue removal profile.

2. The apparatus of claim 1 , wherein the memory comprises the instructions that further cause the apparatus to determine a location of the delicate tissue structure in relation to the tissue removal profile and to display a value of the one or more of a safety parameter or an efficacy parameter.

3. The apparatus of claim 2 , wherein the tissue removal profile comprises one or more protection zones determined based, at least in part, upon one or more of decreasing damage to the delicate tissue structure or avoiding disbursement of a pathogenic tissue.

4. The apparatus of claim 3 , wherein the prostate comprises a delicate tissue structure and the tissue removal profile comprises a protection zone, and the protection zone of the tissue removal profile is determined in response to the image of the prostate and the one or more of the safety parameter or the efficacy parameter.

5. The apparatus of claim 4 , wherein the protection zone is one of a plurality of protection zones, and the plurality of protection zones of the tissue removal profile are determined, at least in response, to the image of the prostate and the one or more of the safety parameter or the efficacy parameter.

6. The apparatus of claim 5 , wherein one or more of the plurality of protection zones are determined, at least in part, based on one or more of avoiding damage to delicate tissue structures or avoiding disbursement of the pathogenic tissue.

7. The apparatus of claim 2 , wherein the safety parameter and the efficacy parameter are generated with a classifier.

8. The apparatus of claim 1 , wherein the delicate tissue structure comprises a verumontanum of the prostate.

9. The apparatus of claim 1 , wherein the delicate tissue structure comprises cancerous tissue.

10. The apparatus of claim 1 , wherein the trained classifier is a trained neural network.

11. The apparatus of claim 1 , wherein the trained classifier is a trained artificial intelligence network.

12. The apparatus of claim 1 , wherein instructions to identify delicate tissue structures of the prostate based on the image include instructions to identify, using the trained classifier, the delicate tissue structures of the prostate within the image.

13. The apparatus of claim 1 , wherein the tissue removal profile includes a cut profile.

14. The apparatus of claim 13 , wherein the cut profile includes a plurality of locations comprising a plurality of angular coordinates about a treatment axis, a plurality of corresponding axial coordinates along the treatment axis, and a plurality of radial distances from the treatment axis.

15. The apparatus of claim 14 , wherein the memory comprises instructions that further cause the apparatus to adjust the cut profile based on the use input.

16. The apparatus of claim 15 , wherein the instructions to adjust the cut profile further include instructions to adjust at least one of:

the plurality of angular coordinates about the treatment axis,

the plurality of corresponding axial coordinates along the axis, or

the plurality of radial distances from the axis.

17. The apparatus of claim 1 , wherein the instructions to identify the delicate tissue structures of the prostate based on the image includes instructions to identify the delicate tissue structures of the prostate with a trained convolutional neural network.

18. The apparatus of claim 1 , wherein the instructions to identify the delicate tissue structures of the prostate based on the image includes instructions to identify the delicate tissue structures of the prostate using edge detection, feature recognition, or segmentation.

19. The apparatus of claim 1 , wherein the instructions to display the tissue removal profile on the display further include instructions to display the image of the prostate with the tissue removal profile in one or more of a sagittal view, parasagittal view, a transverse view, a coronal view, a paracoronal view, or a three-dimensional view.

20. The apparatus of claim 1 , wherein the image of the prostate comprises one or more of tissue margin identification, tissue plane identification, tissue differentiation detection, fluoroscopy, CT scan imaging, magnetic resonance imaging, radioactivity detection, or radiopaque imaging.

Assignments (2)
MERGER Recorded Oct 18, 2024
From: PROCEPT BIOROBOTICS CORPORATION
To: PROCEPT BIOROBOTICS CORPORATION
Reel/Frame 068940/0338 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2024
From: ALJURI, NIKOLAI; MANTRI, SURAG; STAID, KEVIN
To: PROCEPT BIOROBOTICS CORPORATION
Reel/Frame 066631/0967 →
Continuity (3)
Continuation 17250230
Provisional Application 62688349 · Jun 21, 2018
Related Publication 20240277427A1 · Aug 22, 2024
References Cited (90)
US 4742815A · Ninan · 1988 [cited by applicant]
US 6863654B2 · Zappala · 2005 [cited by examiner]
US 8152816B2 · Tuma · 2012 [cited by applicant]
US 8229188B2 · Rusko · 2012 [cited by applicant]
US 9144461B2 · Kruecker · 2015 [cited by applicant]
US 9277969B2 · Brannan · 2016 [cited by applicant]
US 9364251B2 · Aljuri · 2016 [cited by examiner]
US 9549739B2 · Catanese, III · 2017 [cited by examiner]
US 9724069B2 · Neuberger · 2017 [cited by examiner]
US 9867635B2 · Alvarez · 2018 [cited by applicant]
US 10226298B2 · Ourselin · 2019 [cited by applicant]
US 10420616B2 · Kostrzewski · 2019 [cited by applicant]
US 10423757B2 · Kruecker · 2019 [cited by applicant]
US 10448956B2 · Gordon · 2019 [cited by applicant]
US 11278451B2 · Andrews · 2022 [cited by applicant]
US 11963729B2 · Aljuri · 2024 [cited by applicant]
US 20020040220A1 · Zvuloni · 2002 [cited by applicant]
US 20070014454A1 · Sawyer · 2007 [cited by applicant]
US 20080027420A1 · Wang · 2008 [cited by applicant]
US 20080262486A1 · Zvuloni · 2008 [cited by applicant]
US 20100305439A1 · Shai · 2010 [cited by applicant]
US 20110015628A1 · Dalal · 2011 [cited by applicant]
US 20110026786A1 · Mohamed · 2011 [cited by applicant]
US 20110184391A1 · Aljuri · 2011 [cited by applicant]
US 20120277763A1 · Greenblatt · 2012 [cited by applicant]
US 20130090554A1 · Zvuloni · 2013 [cited by applicant]
US 20130317353A1 · Frank · 2013 [cited by applicant]
US 20130317363A1 · Case · 2013 [cited by applicant]
US 20140303659A1 · Aljuri · 2014 [cited by applicant]
US 20140309649A1 · Alvarez · 2014 [cited by applicant]
US 20150025539A1 · Alvarez · 2015 [cited by applicant]
US 20150335344A1 · Aljuri · 2015 [cited by applicant]
US 20160058517A1 · Kim · 2016 [cited by applicant]
US 20160150952A1 · Raymond · 2016 [cited by applicant]
US 20170035611A1 · Dai · 2017 [cited by applicant]
US 20170143428A1 · Raffy · 2017 [cited by applicant]
US 20170273797A1 · Gordon · 2017 [cited by applicant]
US 20180028261A1 · Chen · 2018 [cited by applicant]
US 20180318011A1 · Leibinger · 2018 [cited by applicant]
US 20190201214A1 · Miller · 2019 [cited by applicant]
US 20190254759A1 · Azizian · 2019 [cited by applicant]
US 20190262084A1 · Roh · 2019 [cited by applicant]
US 20190282301A1 · Bonillas Vaca · 2019 [cited by applicant]
US 20220293013A1 · Hannaford · 2022 [cited by applicant]
US 20220415006A1 · Donhowe · 2022 [cited by applicant]
CN 101795636 · 2010 [cited by applicant]
CN 103796607 · 2014 [cited by applicant]
CN 104203078 · 2014 [cited by applicant]
CN 104582624 · 2015 [cited by applicant]
CN 105997245 · 2016 [cited by applicant]
CN 107997821 · 2018 [cited by applicant]
CN 118750165 · 2024 [cited by applicant]
EP 1486900 · 2004 [cited by applicant]
JP 2015509789 · 2015 [cited by applicant]
WO 2008083407 · 2008 [cited by applicant]
WO 2009111736 · 2009 [cited by applicant]
WO 2011097505A1 · 2011 [cited by applicant]
WO 2013053614 · 2013 [cited by applicant]
WO 2013130895A1 · 2013 [cited by applicant]
WO 2014127242A2 · 2014 [cited by applicant]
WO 2014165703A1 · 2014 [cited by applicant]
WO 2015035249A2 · 2015 [cited by applicant]
WO 2015200538A1 · 2015 [cited by applicant]
WO 2016004071A1 · 2016 [cited by applicant]
WO 2016037132A1 · 2016 [cited by applicant]
WO 2016037137A1 · 2016 [cited by applicant]
WO 2017161331A1 · 2017 [cited by applicant]
WO 2018048753 · 2018 [cited by applicant]
WO 2018092071 · 2018 [cited by applicant]
WO 2019032986 · 2019 [cited by applicant]
WO 2019137665 · 2019 [cited by applicant]
WO 2019143635 · 2019 [cited by applicant]
WO 2019204777 · 2019 [cited by applicant]
WO 2019226440 · 2019 [cited by applicant]
WO 2019246580 · 2019 [cited by applicant]
WO 2020117561 · 2020 [cited by applicant]
WO 2020180724 · 2020 [cited by applicant]
WO 2020181278 · 2020 [cited by applicant]
WO 2020181280 · 2020 [cited by applicant]
WO 2020181281 · 2020 [cited by applicant]
WO 2020181290 · 2020 [cited by applicant]
“Clinical Guideline for Benign Prostatic Hyperplasia,” The Japanese Urological Association, pp. 115-116, 125-127, RichHill Medical Inc., machine translation (Apr. 2011). [cited by applicant]
Amended claims filed after receipt of (European) search report dated Sep. 22, 2022 for EP 19821567. NPL2 (Year: 2022). [cited by applicant]
Amendments received before examination dated Sep. 22, 2022 for EP 19821567. NPL3 (Year: 2022). [cited by applicant]
International Search Report and Written Opinion for International Patent Application No. PCT/US2019/038574, 16 pages (Oct. 29, 2019). [cited by applicant]
The Japanese Urological Association, Clinical Guideline for Benign Prostatic Hyperplasia, p. 115-116, 125-127, Japan, Publisher: RichHill Medical Inc., https://222.urol.or.jp.lib/files/other/guideline/08_prostatic_hyper… [cited by applicant]
Macrae, C., Gilling, P., How I do it: Aquablation of the prostate using the AquaBeam system. Can U Urol 23 (6):8590-8593 (2016). [cited by applicant]
AquaBeam System, Instructions for Use (US), provided beginning on Jan. 25, 2018, with products that were sold, not available to public. [cited by applicant]
AquaBeam System, Instructions for Use (US), provided beginning on Jul. 12, 2018, with products that were sold, not available to public. [cited by applicant]
AquaBeam System, Instructions for Use (US), provided beginning on Mar. 27, 2019, with products that were sold, not available to public. [cited by applicant]